Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses

For the past 10 years, disease-modifying therapy (DMT) options for multiple sclerosis (MS) have grown remarkably where DMTs been shown to reduce risk of MS relapses. patients are advised begin treatment with a DMT shortly after diagnosis limit possibility disease progression over time. While radiologically isolated syndrome do not require pharmacologic treatment, high-risk clinically start DMTs. This article provides evidence-based recommendations use in management, helping healthcare practitioners advise on decisions. We aim provide management acute The herein were developed following gathering panel experts evaluating international guidelines, and latest evidence was collected through comprehensive literature review.